Galectin-3 and phagocyte function in severe asthma [ 2016 - 2018 ]

Research Grant

Researchers: Prof Jodie Simpson (Principal investigator) ,  Dr Jay Horvat ,  Dr Katherine Baines

Brief description Asthma, a major chronic inflammatory disease affects more than 2 million Australians. Neutrophilic severe asthma is not responsive to current therapies. We have recently made a significant advance in understanding neutrophilic asthma, reporting low levels of a protein called galectin-3 (gal-3). In this project we will explore the role of gal-3 its effect on the resolution of inflammation. This study will result significantly advance the knowledge of the mechanisms of neutrophilic severe asthma.

Funding Amount $AUD 718,248.86

Funding Scheme Project Grants

Notes Standard Project Grant